Five to 10-year Followup of Open Partial Nephrectomy in a Solitary Kidney
Overview
Affiliations
Purpose: Followup is limited in patients with a solitary kidney who undergo partial nephrectomy. We evaluated overall, cancer specific and recurrence-free survival, and renal function in patients 5 years or greater after open partial nephrectomy.
Materials And Methods: We retrospectively reviewed the Cleveland Clinic kidney cancer database, including only patients with a solitary kidney treated with open partial nephrectomy 5 or more years ago (from 1980 to June 2006) who had 6 months or more of followup. Survival and recurrence analyses were calculated using a Cox proportional hazards model. Results are shown as Kaplan-Meier survival curves. Linear regression analysis was done to assess postoperative renal function.
Results: A total of 282 patients fit our study inclusion criteria (mean followup 175 months), of whom 233 underwent open partial nephrectomy 10 or more years ago. Actual overall survival was 78.5% and 59.5% at 5 and 10 years, respectively. The average estimated glomerular filtration rate at 5 years or greater and 10 years or greater since open partial nephrectomy was 35.1 and 34.5 ml/minute/1.73 m(2) in 89.7% and 89.6%, respectively, of patients with stage 3 or greater chronic kidney disease. Eight survivors were on intermittent hemodialysis 5 years or more postoperatively, including 5 at 10 years or more. There were 76 recurrences for a calculated 5 and 10-year recurrence-free survival rate of 72% (95% CI 66-879) and 63% (95% CI 57-71), respectively.
Conclusions: Open partial nephrectomy in the solitary kidney provides reliable long-term oncological control at 5 and 10 years. Predicted and actual outcomes correspond well. Although most patients have chronic kidney disease postoperatively, it appears stable with minimal progression to dialysis.
Tappero S, Bravi C, Khene Z, Campi R, Pecoraro A, Diana P Ann Surg Oncol. 2024; 31(8):5465-5472.
PMID: 38802714 DOI: 10.1245/s10434-024-15305-w.
Laparoscopic partial versus radical nephrectomy for localized renal cell carcinoma over 4 cm.
Sun Z, Liu F, Wei H, Zhang D J Cancer Res Clin Oncol. 2023; 149(20):17837-17848.
PMID: 37943356 PMC: 10725398. DOI: 10.1007/s00432-023-05487-3.
Schmeusser B, Palacios A, Midenberg E, Nabavizadeh R, Master V, Joshi S Front Oncol. 2022; 12:971341.
PMID: 35992837 PMC: 9382288. DOI: 10.3389/fonc.2022.971341.
Hamilton Z, Uzzo R, Larcher A, Lane B, Ristau B, Capitanio U World J Urol. 2018; 36(8):1255-1262.
PMID: 29532222 DOI: 10.1007/s00345-018-2261-3.
Berczi C Int Urol Nephrol. 2017; 49(2):269-270.
PMID: 28070727 DOI: 10.1007/s11255-016-1500-z.